FDA approves Amgen colon cancer drug Vectibix
295886
The U.S. Food and Drug  Administration said on Wednesday it had approved Amgen Inc's  drug Vectibix for the treatment of advanced colon cancer.
766797
Genentech Inc.  on Monday said its colon cancer drug Avastin extended the life of patients when used in combination with a chemotherapy regimen called FOLFOX4 more than the chemotherapy alone in a late stage clinical trial.
550498
German drug maker Schering AG was  boosted on Thursday as the U.S. Food and Drug Administration  granted its Bonefos treatment "priority review" for preventing  bone tumors in breast cancer patients.
498476
Genentech Inc.  on Monday said its  colon cancer drug Avastin extended the life of patients when  used in combination with a chemotherapy regimen called FOLFOX4  more than the chemotherapy alone in a late stage clinical  trial.
78500
India's Ranbaxy Laboratories Ltd. has received the U.S. Food and Drug Administration's approval for clarithromycin, a generic form of Abbott Laboratories Inc.'s antibiotic Biaxin, the FDA said on Saturday.
651191
Adding the drug Avastin to a  regimen of targeted therapy Erbitux and chemotherapy in  patients with advanced colon cancer is more effective than the  two drugs alone, a leading cancer researcher said on Wednesday.
132487
For those that missed it last night, Biogen Idec (BIIB:Nasdaq - news - research) and Elan Pharmaceuticals (ELN:NYSE ADR - news - research) received FDA approval for their new multiple sclerosis drug, now called Tysabri (formerly known as Antegren.
263089
A Merck &amp; Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells.
349515
WEDNESDAY, Feb. 7 (HealthDay News) -- The first non-prescription drug to treat obesity in American adults was approved Wednesday by the U.S. Food and Drug Administration.
249246
Genentech and Biogen Idec's drug shows positive results against multiple sclerosis.
438501
Here's what a newly approved drug looks like.
485506
A Merck &amp; Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells. The Food and Drug Administration approved the drug, Zolinza, to treat advanced cases of cutaneous T-cell lymphoma, a rare cancer that's a form of non-Hodgkin's lymphoma. Roughly 20,000 Americans have the cancer, Merck said.
18405
The Food and Drug Administration on Tuesday approved a drug for multiple sclerosis that has shown early evidence of being more effective than existing drugs.
554059
A second-line drug to treat a life-threatening form of leukemia has won federal approval, the Food and Drug Administration said Monday.
64799
Merck&#39;s (nyse: MRK - news - people ) decision is based on new three-year data from a clinical trial designed to test the effect of Vioxx on preventing colorectalpolyps.
560148
The Food and Drug Administration approved Clolar, Genzyme Corp.&#39;s new drug for patients under 21 with acute lymphocytic leukemia.
518382
A new drug that fights a form of age-related macular degeneration (AMD), a leading cause of blindness in the elderly, won applause if not approval from a panel of advisors to the US Food and Drug Administration.